Atlas Trials

Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs

Clinical trial NCT00633399 · COMPLETED

Trial details

NCT number
NCT00633399
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2008-07-01
Primary completion
2014-03-01
Enrollment
458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.